| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.895 | 0 | 0.895 | Angiotensin AT1 receptor antagonist | 0.092 0.003 DBMET00008 0.626 0.001 DBMET00302 0.602 0.001 DBMET01051 0.602 0.001 DBMET01052 0.79 0 DBMET01053 0.326 0.001 DBMET01055 0.512 0.001 DBMET01057 0.235 0.001 DBMET01056 | ||
| 0.893 | 0 | 0.893 | Angiotensin II receptor antagonist | 0.116 0.003 DBMET00008 0.639 0.001 DBMET00302 0.622 0.001 DBMET01051 0.622 0.001 DBMET01052 0.806 0 DBMET01053 0.351 0.001 DBMET01055 0.539 0.001 DBMET01057 0.266 0.001 DBMET01056 | ||
| 0.882 | 0.001 | 0.882 | Angiotensin AT1A receptor antagonist | 0.271 0.002 DBMET00008 0.662 0.001 DBMET00302 0.689 0.001 DBMET01051 0.689 0.001 DBMET01052 0.792 0.001 DBMET01053 0.438 0.002 DBMET01055 0.769 0.001 DBMET01057 0.463 0.002 DBMET01056 | ||
| 0.876 | 0 | 0.876 | Angiotensin AT1B receptor antagonist | 0.042 0.003 DBMET00008 0.395 0.001 DBMET00302 0.465 0.001 DBMET01051 0.465 0.001 DBMET01052 0.807 0 DBMET01053 0.151 0.001 DBMET01055 0.435 0.001 DBMET01057 0.156 0.001 DBMET01056 | ||
| 0.777 | 0.001 | 0.777 | Angiotensin AT2 receptor antagonist | 0.158 0.003 DBMET00008 0.477 0.002 DBMET00302 0.512 0.002 DBMET01051 0.512 0.002 DBMET01052 0.639 0.001 DBMET01053 0.329 0.002 DBMET01055 0.605 0.001 DBMET01057 0.346 0.002 DBMET01056 | ||
| 0.538 | 0.022 | 0.538 | 5 Hydroxytryptamine release inhibitor | 0.501 0.032 DBMET00008 0.484 0.038 DBMET00302 0.447 0.053 DBMET01051 0.447 0.053 DBMET01052 0.47 0.043 DBMET01053 0.376 0.095 DBMET01055 0.353 0.113 DBMET01057 0.271 0.2 DBMET01056 | ||
| 0.449 | 0.002 | 0.449 | Phosphodiesterase 7B inhibitor | 0.399 0.003 DBMET00008 0.411 0.003 DBMET00302 0.402 0.003 DBMET01051 0.402 0.003 DBMET01052 0.421 0.002 DBMET01053 0.38 0.003 DBMET01055 0.434 0.002 DBMET01057 0.387 0.003 DBMET01056 | ||
| 0.462 | 0.044 | 0.512 | Histamine release inhibitor | 0.415 0.068 DBMET00008 0.509 0.026 DBMET00302 0.43 0.06 DBMET01051 0.43 0.06 DBMET01052 0.512 0.025 DBMET01053 0.452 0.049 DBMET01055 0.23 0.172 DBMET01057 | DBMET01053 | |
| 0.272 | 0.005 | 0.272 | Phosphodiesterase 3A inhibitor | 0.205 0.008 DBMET00008 0.196 0.009 DBMET00302 0.213 0.007 DBMET01051 0.213 0.007 DBMET01052 0.212 0.007 DBMET01053 0.17 0.012 DBMET01055 0.221 0.006 DBMET01057 0.179 0.011 DBMET01056 | ||
| 0.258 | 0.003 | 0.258 | Phosphodiesterase 1A inhibitor | 0.077 0.018 DBMET00302 0.115 0.008 DBMET01051 0.115 0.008 DBMET01052 0.102 0.009 DBMET01053 0.123 0.007 DBMET01057 0.057 0.048 DBMET01056 | ||
| 0.249 | 0.011 | 0.313 | Catenin beta inhibitor | 0.287 0.006 DBMET00008 0.232 0.015 DBMET00302 0.212 0.024 DBMET01051 0.212 0.024 DBMET01052 0.313 0.005 DBMET01053 0.201 0.031 DBMET01055 0.223 0.019 DBMET01057 0.193 0.038 DBMET01056 | DBMET01053 | |
| 0.254 | 0.042 | 0.361 | Growth hormone agonist | 0.143 0.093 DBMET00008 0.222 0.051 DBMET00302 0.29 0.034 DBMET01051 0.29 0.034 DBMET01052 0.361 0.021 DBMET01053 0.258 0.041 DBMET01055 0.169 0.074 DBMET01057 0.215 0.053 DBMET01056 | DBMET01053 | |
| 0.21 | 0.009 | 0.21 | Phosphodiesterase I inhibitor | 0.094 0.052 DBMET00302 0.109 0.035 DBMET01051 0.109 0.035 DBMET01052 0.106 0.038 DBMET01053 0.13 0.023 DBMET01057 0.079 0.078 DBMET01056 | ||
| 0.191 | 0.012 | 0.191 | Phosphodiesterase 4D inhibitor | 0.117 0.03 DBMET00302 0.171 0.015 DBMET01051 0.171 0.015 DBMET01052 0.145 0.02 DBMET01053 0.113 0.031 DBMET01055 0.15 0.019 DBMET01057 0.135 0.023 DBMET01056 | ||
| 0.182 | 0.008 | 0.228 | Peroxisome proliferator-activated receptor gamma agonist | 0.189 0.007 DBMET00302 0.15 0.013 DBMET01051 0.15 0.013 DBMET01052 0.228 0.005 DBMET01053 0.155 0.012 DBMET01055 0.158 0.011 DBMET01057 0.129 0.018 DBMET01056 | DBMET01053 | |
| 0.171 | 0.005 | 0.171 | Phosphodiesterase 1B inhibitor | 0.071 0.03 DBMET01051 0.071 0.03 DBMET01052 0.066 0.035 DBMET01053 0.073 0.028 DBMET01057 | ||
| 0.169 | 0.004 | 0.211 | Leukotriene D4 antagonist | 0.152 0.005 DBMET00008 0.112 0.005 DBMET00302 0.118 0.005 DBMET01051 0.118 0.005 DBMET01052 0.211 0.004 DBMET01053 0.071 0.007 DBMET01055 0.124 0.005 DBMET01057 0.073 0.007 DBMET01056 | DBMET01053 | |
| 0.175 | 0.015 | 0.306 | Alcohol dehydrogenase inhibitor | 0.211 0.011 DBMET00008 0.26 0.007 DBMET00302 0.12 0.034 DBMET01051 0.12 0.034 DBMET01052 0.306 0.005 DBMET01053 0.152 0.02 DBMET01055 0.132 0.028 DBMET01057 0.095 0.058 DBMET01056 | DBMET01053 | |
| 0.156 | 0.004 | 0.156 | Phosphodiesterase 1C inhibitor | 0.065 0.038 DBMET00302 0.079 0.02 DBMET01051 0.079 0.02 DBMET01052 0.08 0.02 DBMET01053 0.079 0.02 DBMET01057 | ||
| 0.155 | 0.005 | 0.155 | Fatty acid synthase inhibitor | 0.062 0.033 DBMET00302 0.109 0.009 DBMET01051 0.109 0.009 DBMET01052 0.091 0.014 DBMET01053 0.061 0.035 DBMET01057 | ||
| 0.154 | 0.005 | 0.154 | Glutamate (mGluR group II) agonist | 0.122 0.005 DBMET00008 0.109 0.006 DBMET00302 0.116 0.005 DBMET01051 0.116 0.005 DBMET01052 0.144 0.005 DBMET01053 0.079 0.009 DBMET01055 0.117 0.005 DBMET01057 0.08 0.009 DBMET01056 | ||
| 0.147 | 0.004 | 0.147 | Glutamate (mGluR2) agonist | 0.114 0.005 DBMET00008 0.103 0.006 DBMET00302 0.109 0.005 DBMET01051 0.109 0.005 DBMET01052 0.13 0.005 DBMET01053 0.074 0.009 DBMET01055 0.11 0.005 DBMET01057 0.075 0.009 DBMET01056 | ||
| 0.23 | 0.096 | 0.267 | Cardiotonic | 0.267 0.072 DBMET00302 0.239 0.09 DBMET01051 0.239 0.09 DBMET01052 0.192 0.126 DBMET01053 0.265 0.072 DBMET01055 0.163 0.16 DBMET01056 | DBMET00302 | |
| 0.129 | 0.005 | 0.135 | Bombesin 3 receptor antagonist | 0.135 0.005 DBMET00008 0.109 0.009 DBMET00302 0.103 0.011 DBMET01051 0.103 0.011 DBMET01052 0.106 0.01 DBMET01053 0.087 0.016 DBMET01055 0.114 0.008 DBMET01057 0.085 0.017 DBMET01056 | DBMET00008 | |
| 0.127 | 0.005 | 0.127 | Phosphodiesterase VII inhibitor | 0.088 0.019 DBMET00008 0.106 0.01 DBMET00302 0.111 0.008 DBMET01051 0.111 0.008 DBMET01052 0.112 0.008 DBMET01053 0.099 0.013 DBMET01055 0.114 0.008 DBMET01057 0.1 0.013 DBMET01056 | ||
| 0.127 | 0.01 | 0.127 | Phosphodiesterase 4C inhibitor | 0.065 0.03 DBMET00302 0.104 0.014 DBMET01051 0.104 0.014 DBMET01052 0.072 0.025 DBMET01053 0.061 0.034 DBMET01055 0.076 0.023 DBMET01057 0.067 0.029 DBMET01056 | ||
| 0.135 | 0.022 | 0.175 | Glutamate receptor agonist | 0.07 0.062 DBMET00008 0.175 0.014 DBMET01053 | DBMET01053 | |
| 0.116 | 0.019 | 0.116 | Glutamate (mGluR) agonist | 0.076 0.033 DBMET00008 0.061 0.044 DBMET00302 0.063 0.042 DBMET01051 0.063 0.042 DBMET01052 0.106 0.022 DBMET01053 0.065 0.041 DBMET01057 | ||
| 0.099 | 0.005 | 0.101 | Nicotinic acid receptor 2 agonist | 0.101 0.005 DBMET00008 0.061 0.011 DBMET00302 0.057 0.012 DBMET01051 0.057 0.012 DBMET01052 0.085 0.007 DBMET01053 0.039 0.021 DBMET01055 0.055 0.012 DBMET01057 0.036 0.024 DBMET01056 | DBMET00008 | |
| 0.098 | 0.008 | 0.123 | Sphingosine kinase 2 inhibitor | 0.111 0.005 DBMET00008 0.072 0.02 DBMET00302 0.123 0.005 DBMET01051 0.123 0.005 DBMET01052 0.081 0.015 DBMET01055 0.061 0.031 DBMET01056 | DBMET01052 | |
| 0.089 | 0.005 | 0.097 | Glutamate (mGluR group II) antagonist | 0.043 0.021 DBMET00008 0.051 0.015 DBMET00302 0.083 0.006 DBMET01051 0.083 0.006 DBMET01052 0.097 0.005 DBMET01053 0.043 0.021 DBMET01055 0.04 0.025 DBMET01057 0.037 0.028 DBMET01056 | DBMET01053 | |
| 0.09 | 0.009 | 0.09 | Kinesin-like protein 1 inhibitor | 0.057 0.014 DBMET00302 0.04 0.022 DBMET01051 0.04 0.022 DBMET01052 0.057 0.014 DBMET01053 0.034 0.03 DBMET01055 0.049 0.017 DBMET01057 | ||
| 0.09 | 0.009 | 0.09 | Kinesin antagonist | 0.057 0.014 DBMET00302 0.04 0.022 DBMET01051 0.04 0.022 DBMET01052 0.057 0.014 DBMET01053 0.034 0.03 DBMET01055 0.049 0.017 DBMET01057 | ||
| 0.085 | 0.006 | 0.099 | AMPA 2 receptor antagonist | 0.096 0.005 DBMET00008 0.048 0.011 DBMET00302 0.051 0.011 DBMET01051 0.051 0.011 DBMET01052 0.099 0.005 DBMET01053 0.033 0.018 DBMET01055 0.046 0.012 DBMET01057 0.031 0.02 DBMET01056 | DBMET01053 | |
| 0.099 | 0.023 | 0.099 | Phosphodiesterase III inhibitor | 0.062 0.05 DBMET00008 0.089 0.028 DBMET00302 0.073 0.041 DBMET01051 0.073 0.041 DBMET01052 0.091 0.027 DBMET01053 0.07 0.044 DBMET01055 0.097 0.024 DBMET01057 0.072 0.042 DBMET01056 | ||
| 0.072 | 0.005 | 0.072 | Glutamate (mGluR2) antagonist | 0.028 0.024 DBMET00008 0.036 0.014 DBMET00302 0.059 0.006 DBMET01051 0.059 0.006 DBMET01052 0.06 0.006 DBMET01053 0.029 0.022 DBMET01055 0.03 0.02 DBMET01057 | ||
| 0.131 | 0.07 | 0.131 | NADPH oxidase inhibitor | 0.107 0.101 DBMET01053 | ||
| 0.076 | 0.019 | 0.097 | Sphingosine kinase inhibitor | 0.094 0.009 DBMET00008 0.065 0.031 DBMET00302 0.097 0.008 DBMET01051 0.097 0.008 DBMET01052 0.072 0.022 DBMET01055 | DBMET01052 | |
| 0.084 | 0.028 | 0.084 | Phosphodiesterase VIII inhibitor | 0.072 0.05 DBMET00302 0.072 0.048 DBMET01051 0.072 0.048 DBMET01052 0.071 0.051 DBMET01053 0.075 0.044 DBMET01057 | ||
| 0.051 | 0.01 | 0.067 | Endothelin receptor antagonist | 0.031 0.017 DBMET00302 0.027 0.02 DBMET01051 0.027 0.02 DBMET01052 0.067 0.008 DBMET01053 0.039 0.013 DBMET01057 | DBMET01053 | |
| 0.118 | 0.08 | 0.137 | Acetylcholinesterase inhibitor | 0.137 0.064 DBMET01057 | DBMET01057 | |
| 0.057 | 0.02 | 0.057 | Phosphodiesterase 3B inhibitor | 0.045 0.029 DBMET00008 0.05 0.025 DBMET00302 0.045 0.03 DBMET01051 0.045 0.03 DBMET01052 0.055 0.022 DBMET01053 0.041 0.035 DBMET01055 0.051 0.024 DBMET01057 0.041 0.034 DBMET01056 | ||
| 0.05 | 0.015 | 0.064 | AMPA 4 receptor antagonist | 0.058 0.011 DBMET00008 0.064 0.009 DBMET01053 | DBMET01053 | |
| 0.058 | 0.026 | 0.061 | Carbonic anhydrase II stimulant | 0.061 0.022 DBMET00008 0.047 0.046 DBMET00302 0.047 0.046 DBMET01051 0.047 0.046 DBMET01052 0.058 0.025 DBMET01053 | DBMET00008 | |
| 0.046 | 0.017 | 0.06 | Glucagon-like peptide 1 receptor antagonist | 0.04 0.026 DBMET00008 0.045 0.019 DBMET00302 0.06 0.008 DBMET01053 | DBMET01053 | |
| 0.045 | 0.017 | 0.045 | Nicotinic acid receptor agonist | 0.037 0.023 DBMET00008 0.036 0.025 DBMET01053 0.032 0.031 DBMET01057 | ||
| 0.057 | 0.031 | 0.058 | Autotaxin inhibitor | 0.054 0.034 DBMET01051 0.054 0.034 DBMET01052 0.058 0.03 DBMET01053 | DBMET01053 | |
| 0.05 | 0.025 | 0.121 | NMDA receptor subunit 3B antagonist | 0.048 0.027 DBMET00008 0.121 0.009 DBMET01053 | DBMET01053 | |
| 0.057 | 0.038 | 0.069 | Leukotriene C antagonist | 0.057 0.036 DBMET00008 0.069 0.014 DBMET01053 | DBMET01053 | |
| 0.029 | 0.014 | 0.033 | Kainate receptor 4 antagonist | 0.029 0.014 DBMET00008 0.033 0.012 DBMET01053 | DBMET01053 | |
| 0.039 | 0.025 | 0.046 | Carbonic anhydrase I stimulant | 0.046 0.019 DBMET00008 0.041 0.023 DBMET01053 | DBMET00008 | |
| 0.035 | 0.021 | 0.035 | Growth hormone releasing factor agonist | |||
| 0.065 | 0.056 | 0.065 | Cannabinoid receptor antagonist | |||
| 0.029 | 0.021 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 DBMET00008 0.049 0.009 DBMET01053 | DBMET01053 | |
| 0.101 | 0.095 | 0.133 | Glutamate receptor antagonist | 0.133 0.063 DBMET00008 0.103 0.093 DBMET00302 0.114 0.08 DBMET01053 | DBMET00008 | |
| 0.057 | 0.051 | 0.11 | Prostaglandin F2 alpha antagonist | 0.11 0.009 DBMET00302 0.067 0.035 DBMET01051 0.067 0.035 DBMET01052 0.094 0.014 DBMET01053 0.11 0.009 DBMET01055 | DBMET01055 | |
| 0.022 | 0.016 | 0.022 | Bombesin agonist | |||
| 0.053 | 0.048 | 0.053 | CXC chemokine 4 receptor antagonist | |||
| 0.044 | 0.04 | 0.044 | Phosphodiesterase 4A inhibitor | |||
| 0.018 | 0.014 | 0.018 | Bombesin 3 receptor agonist | |||
| 0.058 | 0.054 | 0.102 | Leukotriene antagonist | 0.064 0.046 DBMET00008 0.058 0.054 DBMET00302 0.102 0.021 DBMET01053 | DBMET01053 | |
| 0.02 | 0.016 | 0.025 | Endothelin A receptor antagonist | 0.025 0.012 DBMET01053 | DBMET01053 | |
| 0.034 | 0.03 | 0.089 | NMDA receptor subunit 3A antagonist | 0.089 0.01 DBMET01053 | DBMET01053 | |
| 0.017 | 0.015 | 0.017 | Growth hormone release promoting | |||
| 0.036 | 0.037 | 0.046 | Leukotriene C4 antagonist | 0.037 0.034 DBMET00008 0.046 0.014 DBMET01053 | DBMET01053 | |
| 0.012 | 0.016 | 0.014 | Carbonic anhydrase IV stimulant | 0.014 0.013 DBMET00008 | DBMET00008 | |
| 0.016 | 0.02 | 0.021 | Kainate receptor 5 antagonist | 0.021 0.014 DBMET01053 | DBMET01053 | |
| 0.018 | 0.022 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 DBMET00008 0.025 0.012 DBMET01053 | DBMET01053 | |
| 0.014 | 0.018 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.013 DBMET01053 | DBMET01053 | |
| 0.023 | 0.028 | 0.028 | Nicotinic acid receptor 2 antagonist | 0.028 0.016 DBMET00008 | DBMET00008 | |
| 0.037 | 0.046 | 0.071 | Glutamate (mGluR4) antagonist | 0.042 0.034 DBMET00008 0.071 0.01 DBMET01053 | DBMET01053 | |
| 0.011 | 0.026 | 0.029 | Kainate receptor 1 antagonist | 0.029 0.011 DBMET01053 | DBMET01053 | |
| 0.11 | 0.124 | 0.118 | Cholinergic | 0.118 0.11 DBMET01057 | DBMET01057 | |
| 0.05 | 0.068 | 0.097 | Sphingosine 1-phosphate receptor 4 agonist | 0.097 0.026 DBMET01053 | DBMET01053 | |
| 0.045 | 0.066 | 0.067 | Sphingosine 1-phosphate receptor 5 agonist | 0.067 0.018 DBMET01053 | DBMET01053 | |
| 0.015 | 0.036 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.019 DBMET01053 | DBMET01053 | |
| 0.016 | 0.041 | 0.041 | Prostaglandin EP4 antagonist | 0.041 0.01 DBMET01053 | DBMET01053 | |
| 0.015 | 0.041 | 0.032 | Leukotriene B4 receptor 1 antagonist | 0.032 0.017 DBMET01053 | DBMET01053 | |
| 0.035 | 0.063 | 0.054 | Glutamate (mGluR group III) antagonist | 0.054 0.017 DBMET01053 | DBMET01053 | |
| 0.022 | 0.056 | 0.044 | Kainate receptor antagonist | 0.044 0.025 DBMET01053 | DBMET01053 | |
| 0.034 | 0.093 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 DBMET01053 | DBMET01053 | |
| 0.026 | 0.112 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.044 DBMET01053 | DBMET01053 | |
| 0.096 | 0.183 | 0.125 | Hemostatic | 0.124 0.106 DBMET00008 0.125 0.104 DBMET01053 | DBMET01053 | |
| 0.022 | 0.125 | 0.034 | Glutamate (mGluR8) antagonist | 0.034 0.03 DBMET01053 | DBMET01053 | |
| 0.015 | 0.166 | 0.065 | Prostaglandin antagonist | 0.065 0.029 DBMET01053 | DBMET01053 | |
| 0.085 | 0.242 | 0.262 | Hypolipemic | 0.223 0.081 DBMET00302 0.15 0.136 DBMET01051 0.15 0.136 DBMET01052 0.262 0.062 DBMET01055 | DBMET01055 | |
| 0.098 | 0.372 | 0.567 | Antiobesity | 0.567 0.025 DBMET00008 | DBMET00008 | |
| 0.051 | 0.333 | 0.122 | Farnesoid X receptor antagonist | 0.122 0.099 DBMET01056 | DBMET01056 | |
| 0.019 | 0.357 | 0.054 | Bombesin 1 receptor agonist | 0.054 0.049 DBMET00008 | DBMET00008 | |
| 0.019 | 0.374 | 0.113 | HIV-1 integrase inhibitor | 0.113 0.018 DBMET00008 | DBMET00008 | |
| 0.1 | 0.477 | 0.451 | Cyclophilin D inhibitor | 0.451 0.067 DBMET00008 0.247 0.217 DBMET00302 0.249 0.214 DBMET01051 0.249 0.214 DBMET01052 0.264 0.197 DBMET01053 0.345 0.126 DBMET01055 | DBMET00008 | |
| 0.079 | 0.466 | 0.249 | Sodium/bile acid cotransporter inhibitor | 0.249 0.129 DBMET01051 0.249 0.129 DBMET01052 0.198 0.191 DBMET01053 0.203 0.184 DBMET01055 | DBMET01052 | |
| 0.02 | 0.425 | 0.069 | Vanilloid 2 antagonist | 0.069 0.015 DBMET00008 | DBMET00008 | |
| 0.095 | 0.505 | 0.217 | Interleukin 2 agonist | 0.217 0.161 DBMET01051 0.217 0.161 DBMET01052 | DBMET01052 | |
| 0.037 | 0.59 | 0.207 | Immunosuppressant | 0.207 0.19 DBMET01056 | DBMET01056 | |
| 0.003 | 0.598 | 0.038 | HMG CoA reductase inhibitor | 0.038 0.017 DBMET01055 | DBMET01055 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |